New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
Retrieved on:
Friday, November 5, 2021
Cardiology, Biotechnology, Surgery, General Health, Health, Medical Devices, Clinical Trials, Other Health, Myocardial infarction, Columbia University Irving Medical Center, TIMI, Safety, TCT, Șaeș, CAT, Medicine, Culture, Perfusion, MBG, Heart, Security (finance), Thrombus, Technology, Failure, Trial of the century, Investment, MACE, Use, COVID-19, Multimedia, Stroke, Annual report, PCI, Twitter, Contraindication, Percutaneous coronary intervention, Incidence, Manatee Memorial Hospital, Hospital, U.S. Securities and Exchange Commission, NYHA, Columbia University, LinkedIn, SEC, Nature, NYSE, Physician, Time, Joe Byrd (Cherokee Nation Principal Chief), Patient, Reperfusion, Acute coronary syndrome, Cardiogenic shock, Pharmaceutical industry, Risk management, the CHEETAH Study, Penumbra, THE CHEETAH STUDY, PENUMBRA
After only one pass with Penumbras CAT RX, we were pleased to see restoration of blood flow and perfusion when used upfront in acute coronary syndrome interventions.
Key Points:
- After only one pass with Penumbras CAT RX, we were pleased to see restoration of blood flow and perfusion when used upfront in acute coronary syndrome interventions.
- The CHEETAH clinical study enrolled 400 patients with high thrombus burden who were treated with continuous mechanical aspiration thrombectomy with CAT RX prior to PCI.
- As part of the Indigo Aspiration System, the Indigo CAT RX Aspiration Catheters and Indigo Separator 4 are indicated for the removal of fresh, soft emboli and thrombi from vessels in the coronary and peripheral vasculature.
- The CHEETAH study suggests that CAT RX power aspiration is both safe and effective in a high-risk coronary patient population.